A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
A quartet of ETFs faceplanted last year, but they could mount a comeback this year.
Another month, another Consumer Price Index inflation report, the show-stopping data dump of our inflation-weary universe.
The focus will be on mining earth metals including lithium, zinc, copper and nickel, all crucial metals for battery-making.